This Startup Is Developing Finger-Prick Blood Tests, But Don’t Call It Theranos 2

Sight Diagnostics believes it can succeed where Theranos failed, developing rapid finger-prick blood tests, but it’s approach is nothing like that of the failed Silicon Valley startup chronicled in the bestselling book Bad Blood.

Read the full post on Forbes - Healthcare